Physician profile
Mark C Drakos
NPI 1962613661
$26,917.32
in general payments reported to CMS, 2019-2025
13 companies · $6,602 in 2025
The $6,602 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,344 · 2020: $1,336 · 2021: $8,092 · 2022: $1,482 · 2023: $2,326 · 2024: $4,735 · 2025: $6,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $9,435 · Consulting Fee: $2,500 · Food and Beverage: $1,080 · Travel and Lodging: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $9,435.00 |
| Consulting Fee | $2,500.00 |
| Food and Beverage | $1,080.23 |
| Travel and Lodging | $648.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $15,444.31 | 2019-2025 | Jones, Jones Screw, Io Fix |
| Arthrex, INC. | $6,858.87 | 2021-2024 | |
| Gotham Surgical Solutions & Devices, INC. | $2,062.00 | 2019-2021 | |
| Depuy Synthes Products, INC. | $877.50 | 2019 | |
| Suvon Surgical LLC | $670.41 | 2022-2025 | |
| Kci USA, INC. | $400.00 | 2020 | |
| Stryker Corporation | $220.87 | 2024-2025 | Inbone |
| Wright Medical Technology, INC. | $119.22 | 2020 | |
| Lifenet Health | $98.58 | 2025 | Duallink |
| Djo, LLC | $94.40 | 2023 | Cmf |
| Alafair Biosciences, INC. | $57.31 | 2025 | Versawrap |
| Kairos Surgical INC | $13.85 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Drakos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.